热门资讯> 正文
Bavarian Nordic在收购要约后攀升
2025-07-24 23:25
- Shares of Bavarian Nordic (OTCPK:BVNRY) (BAVN) (OTCPK:BVNKF) closed ~22% higher in European trading on Thursday after the Danish biotech announced a takeover offer from private equity groups Nordic Capital and Permira.
- The maker of the Jynneos mpox vaccine didn’t disclose the size of Nordic Capital and Permira's offer for the company, which had a market capitalization of approximately DKK 18.1B ($2.9B) as of Thursday’s market close.
- "As these discussions are continuing, there can be no certainty as to whether any offer for Bavarian Nordic A/S by Nordic Capital and Permira will be made, or the timing or the terms of such offer," Reuters reported, referring to a company statement.
- Seeking Alpha analyst Myriam Alvarez upgraded Bavarian Nordic (OTCPK:BVNRY) to Strong Buy from Buy in April, citing, among other things, a compelling valuation following the stock’s recent sell-off.
More on Bavarian Nordic
- Bavarian Nordic A/S (BVNKF) Q1 2025 Earnings Call Transcript
- Bavarian Nordic A/S 2025 Q1 - Results - Earnings Call Presentation
- Bavarian Nordic sells its Priority Review Voucher for $160M
- Historical earnings data for Bavarian Nordic A/S
- Financial information for Bavarian Nordic A/S
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
